CD8A and neurofibromatosis type 1: Quantification of circulating lymphocyte populations in the peripheral blood of NF1 patients using flow cytometry revealed increased effector CD8+/CD27- and activated CD8+/CD57+ T-cell populations in subjects with low PNF and CNF tumor burden compared to patients with high tumor burden [105].